Published in Arch Ophthalmol on August 01, 2002
Obesity and eye diseases. Surv Ophthalmol (2007) 2.13
Age related macular degeneration. BMJ (2003) 1.72
Further validation of the Daily Living Tasks Dependent on Vision: identification of domains. Br J Ophthalmol (2005) 0.93
Visual acuity and contrast sensitivity in patients with neovascular age-related macular degeneration. Results from the Radiation Therapy for Age-Related Macular Degeneration (RAD-) Study. Graefes Arch Clin Exp Ophthalmol (2003) 0.91
Ten-year follow-up of eyes treated with stereotactic fractionated external beam radiation for neovascular age-related macular degeneration. Retina (2011) 0.85
Formal and informal care utilisation amongst elderly persons with visual impairment. Br J Ophthalmol (2007) 0.84
[Radiotherapy of non-malignant diseases. Past, present and future]. Strahlenther Onkol (2012) 0.84
25th RCOphth Congress, President's Session paper: 25 years of progress in medical retina. Eye (Lond) (2014) 0.80
Visual functioning and quality of life in the SubFoveal Radiotherapy Study (SFRADS): SFRADS report 2. Br J Ophthalmol (2005) 0.80
Clinicopathological correlation of choroidal neovascularization after external beam radiotherapy in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2003) 0.78
[In Process Citation]. Ophthalmologe (2015) 0.78
Radiotherapy for recurrent choroidal neovascularisation complicating age related macular degeneration. Br J Ophthalmol (2004) 0.75
Epimacular brachytherapy - old ghost or new age? Graefes Arch Clin Exp Ophthalmol (2011) 0.75
An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol (1995) 10.05
Chromosome 5 allele loss in human colorectal carcinomas. Nature (1987) 4.46
Distribution of fundus autofluorescence with a scanning laser ophthalmoscope. Br J Ophthalmol (1995) 3.62
A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy. Nat Genet (1999) 3.32
X-linked retinitis pigmentosa. Br J Ophthalmol (1975) 3.11
Tears of detached retinal pigment epithelium. Br J Ophthalmol (1981) 3.08
A human homolog of yeast pre-mRNA splicing gene, PRP31, underlies autosomal dominant retinitis pigmentosa on chromosome 19q13.4 (RP11). Mol Cell (2001) 3.07
Identification of a defect in DNA ligase IV in a radiosensitive leukaemia patient. Curr Biol (1999) 2.98
Influence of hospital and clinician workload on survival from colorectal cancer: cohort study. BMJ (1999) 2.98
A new locus for autosomal dominant retinitis pigmentosa on chromosome 7p. Nat Genet (1993) 2.97
Mutational hot spot within a new RPGR exon in X-linked retinitis pigmentosa. Nat Genet (2000) 2.82
Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation. Br J Ophthalmol (2006) 2.67
Close genetic linkage between X-linked retinitis pigmentosa and a restriction fragment length polymorphism identified by recombinant DNA probe L1.28. Nature (1984) 2.52
Mutations in the pre-mRNA splicing factor gene PRPC8 in autosomal dominant retinitis pigmentosa (RP13). Hum Mol Genet (2001) 2.48
RPGR mutation associated with retinitis pigmentosa, impaired hearing, and sinorespiratory infections. J Med Genet (2003) 2.45
Long-term follow-up of central serous chorioretinopathy. Br J Ophthalmol (1984) 2.40
Fundus autofluorescence in age-related macular disease imaged with a laser scanning ophthalmoscope. Invest Ophthalmol Vis Sci (1997) 2.31
Treatment of age-related subfoveal neovascular membranes by teletherapy: a pilot study. Br J Ophthalmol (1993) 2.21
The development of neovascularization of senile disciform macular degeneration. Am J Ophthalmol (1973) 2.17
Recent advances in the treatment of senile disciform macular degeneration by photocoagulation. Br J Ophthalmol (1974) 2.14
In vivo fundus autofluorescence in macular dystrophies. Arch Ophthalmol (1997) 2.10
Senile disciform macular degeneration in the second eye. Br J Ophthalmol (1977) 2.07
Bilateral acute retinal necrosis. Br J Ophthalmol (1978) 2.07
Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration. Ophthalmology (2006) 2.04
Phenotypic subtypes of Stargardt macular dystrophy-fundus flavimaculatus. Arch Ophthalmol (2001) 2.04
Aging changes in Bruch's membrane. A histochemical and morphologic study. Ophthalmology (1990) 1.99
Optimizing the initial 12-lead electrocardiographic diagnosis of acute myocardial infarction. Eur Heart J (2000) 1.93
Treatment of chronic macular edema with acetazolamide. Arch Ophthalmol (1988) 1.90
A 3-bp deletion in the rhodopsin gene in a family with autosomal dominant retinitis pigmentosa. Am J Hum Genet (1991) 1.88
A clinical, psychophysical, and electroretinographic survey of patients with autosomal dominant retinitis pigmentosa. Br J Ophthalmol (1985) 1.87
The VALUE national hysterectomy study: description of the patients and their surgery. BJOG (2002) 1.86
Antimicrobial susceptibility testing of Actinomyces species with 12 antimicrobial agents. J Antimicrob Chemother (2005) 1.86
Mutations in the retinal guanylate cyclase (RETGC-1) gene in dominant cone-rod dystrophy. Hum Mol Genet (1998) 1.84
Amblyopia: is visual loss permanent? Br J Ophthalmol (2000) 1.81
A mutation in guanylate cyclase activator 1A (GUCA1A) in an autosomal dominant cone dystrophy pedigree mapping to a new locus on chromosome 6p21.1. Hum Mol Genet (1998) 1.81
A completed screen for mutations of the rhodopsin gene in a panel of patients with autosomal dominant retinitis pigmentosa. Hum Mol Genet (1992) 1.80
A mutation in NRL is associated with autosomal dominant retinitis pigmentosa. Nat Genet (1999) 1.79
Isolation of nonsense mutants of lipid-containing bacteriophage PRD1. J Virol (1982) 1.78
A clinical study of the vascularity of senile disciform macular degeneration. Am J Ophthalmol (1973) 1.77
Validation of an outcome scale for use in adult psychiatric practice. Qual Health Care (2000) 1.75
Degenerative changes in a retina affected with autosomal dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci (1989) 1.75
Retinal pigment epithelial detachments in the elderly: classification and outcome. Br J Ophthalmol (1985) 1.74
Functional characterisation and serial imaging of abnormal fundus autofluorescence in patients with retinitis pigmentosa and normal visual acuity. Br J Ophthalmol (2006) 1.74
Pigment epithelial detachment in the elderly. Clinical differentiation, natural course and pathogenetic implications. Graefes Arch Clin Exp Ophthalmol (2002) 1.74
Prevalence of helmet use among motorcycle riders in Vietnam. Inj Prev (2006) 1.72
Vascular tufts at the pupillary margin in myotonic dystrophy. Am J Ophthalmol (1970) 1.71
Identification of a sixth locus for autosomal dominant retinitis pigmentosa on chromosome 19. Hum Mol Genet (1994) 1.71
Acute zonal occult outer retinopathy: towards a set of diagnostic criteria. Br J Ophthalmol (2005) 1.70
Functional loss in age-related Bruch's membrane change with choroidal perfusion defect. Invest Ophthalmol Vis Sci (1992) 1.69
Superficial granular corneal dystrophy with amyloid deposits. Arch Ophthalmol (1992) 1.68
Choroidal perfusion abnormality with age-related Bruch's membrane change. Am J Ophthalmol (1990) 1.66
Retinal vascular abnormalities in facioscapulohumeral muscular dystrophy. A general association with genetic and therapeutic implications. Brain (1987) 1.66
Drusen as risk factors in age-related macular disease. Am J Ophthalmol (1990) 1.66
Autosomal dominant exudative vitreoretinopathy. Br J Ophthalmol (1980) 1.65
Retinal macroaneurysms. Br J Ophthalmol (1975) 1.64
Retinopathy in haemoglobin C trait. Eye (Lond) (1996) 1.63
The role of axoplasmic transport in the pathogenesis of retinal cotton-wool spots. Br J Ophthalmol (1977) 1.62
Relationship between melatonin rhythms and visual loss in the blind. J Clin Endocrinol Metab (1997) 1.58
Vitamin A treatment for night blindness in primary biliary cirrhosis. Br Med J (Clin Res Ed) (1984) 1.57
Walking to school and traffic exposure in Australian children. Aust N Z J Public Health (1997) 1.56
Analysis of lipid deposits extracted from human macular and peripheral Bruch's membrane. Arch Ophthalmol (1994) 1.55
Comparison of natural with clomiphene citrate-stimulated cycles in in vitro fertilization: a prospective, randomized trial. Fertil Steril (1994) 1.55
Fusobacterium necrophorum infections in England and Wales 1990-2000. J Med Microbiol (2002) 1.55
Senile disciform macular degeneration: features indicating suitability for photocoagulation. Br J Ophthalmol (1979) 1.54
Retinal venous sheathing in optic neuritis. Its significance for the pathogenesis of multiple sclerosis. Brain (1987) 1.54
Incidence of aphakic macular oedema. A prospective study. Br J Ophthalmol (1975) 1.54
Symptomatic abnormalities of dark adaptation in patients with age-related Bruch's membrane change. Br J Ophthalmol (1993) 1.51
On the retinal vasculature of the human fovea. Exp Eye Res (1974) 1.50
Assembly of bacteriophage PRD1: particle formation with wild-type and mutant viruses. J Virol (1982) 1.49
Bilateral macular drusen in age-related macular degeneration. Prognosis and risk factors. Ophthalmology (1994) 1.49
Macular degeneration: do conventional measurements of impaired visual function equate with visual disability? Br J Ophthalmol (2000) 1.49
Low vision services for vision rehabilitation in the United Kingdom. Br J Ophthalmol (2002) 1.47
Choroidal neovascularization as a late complication of ocular toxoplasmosis. Am J Ophthalmol (1981) 1.46
Autosomal dominant retinitis pigmentosa: four new mutations in rhodopsin, one of them in the retinal attachment site. Genomics (1991) 1.46
Long-term management of abetalipoproteinaemia. Possible role for vitamin E. Arch Dis Child (1977) 1.44
CNV subtype in first eyes predicts severity of ARM in fellow eyes. Br J Ophthalmol (2003) 1.44
A multidisciplinary team approach to skull base chordomas. J Neurosurg (2001) 1.44
The use of corticosteroids for choroidal neovascularisation in young patients. Eye (Lond) (1998) 1.43
Histopathology of ruby and argon laser lesions in monkey and human retina. A comparative study. Br J Ophthalmol (1975) 1.42
Histopathology of incipient fundus flavimaculatus. Ophthalmology (1991) 1.42
Radiotherapy for age-related macular degeneration. Clin Oncol (R Coll Radiol) (1998) 1.41
Autosomal dominant retinitis pigmentosa with apparent incomplete penetrance: a clinical, electrophysiological, psychophysical, and molecular genetic study. Br J Ophthalmol (1993) 1.41
A comparative histopathological study of argon and krypton laser irradiations of the human retina. Br J Ophthalmol (1979) 1.41
Functional correlates of fundus autofluorescence abnormalities in patients with RPGR or RIMS1 mutations causing cone or cone rod dystrophy. Br J Ophthalmol (2007) 1.40
The role of molecular genetics in the prenatal diagnosis of retinal dystrophies. Eye (Lond) (1995) 1.39
A linkage survey of 20 dominant retinitis pigmentosa families: frequencies of the nine known loci and evidence for further heterogeneity. J Med Genet (1998) 1.39
Sorsby's fundus dystrophy. A light and electron microscopic study. Ophthalmology (1989) 1.38
Relation between plasma norepinephrine and response to medical therapy in men with congestive heart failure secondary to coronary artery disease or idiopathic dilated cardiomyopathy. Am J Cardiol (1989) 1.38
Experimental retinal branch vein occlusion in rhesus monkeys. I. Clinical appearances. Br J Ophthalmol (1979) 1.37
Fruits and vegetables that are sources for lutein and zeaxanthin: the macular pigment in human eyes. Br J Ophthalmol (1998) 1.35
Subfoveal choroidal neovascular membranes in age-related macular degeneration. Visual prognosis in eyes with relatively good initial visual acuity. Arch Ophthalmol (1986) 1.35
Orbital recurrence of retinoblastoma. Ophthalmic Paediatr Genet (1987) 1.34